Former CEO of Insys Therapeutics, Michael Babich, has set to plead guilty in a major opiate drug case. Babich said he will plead guilty when he takes on trial in January. He will plead guilty to conspiracy and mail & wire fraud and forfeit $3.5m.
He has been charged in a national scheme of bribing doctors in return for prescribing patients Subsys, which is a fentanyl based painkiller and is found to be an highly addictive drug.
A man reported that he had been receiving fentanyl via mail for approximately two years, not knowing it was illegal.
That's a huge domino to fall in a case scheduled for trial next month. Alec Burlakoff, Insys' ex-head of sales, already pled guilty and agreed to cooperate. John Kapoor, the company's mega-rich owner, has stood firm along with four other defendants.
— Aaron Leibowitz (@aaron_leib) December 26, 2018
Subsys, an under-the-tongue spray that manages pain in cancer patients, contains fentanyl, an opioid that the U.S. Drug Enforcement Administration says is 25 to 50 times more powerful than heroin. It is the drug that killed Prince.
— Wendy (@WendyAtTheBay) December 15, 2018